Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
- Posted on October 2, 2026
- By CNBC
- 1 Views
- 1 min read
In brief
Generating AI summary…
Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
